AI assistant
Sending…
ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2025
Nov 10, 2025
33148_dirs_2025-11-10_c4bf722c-1d2f-4779-92e6-30b580d86b53.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2025-11-03
Reporting Person: Wilson Martin (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-03 | Common Stock | A | 100000 | — | Acquired | 385462 | Direct |
Footnotes
F1: Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
F2: Represent RSUs that convert to common stock on a one-for-one basis. The RSUs will become fully vested on November 3, 2026.
More from ROCKET PHARMACEUTICALS, INC.
Merger & Acquisition
2026
May 28
Regulatory Filings
2026
May 21
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 26
Director's Dealing
2026
Feb 20